Clinical Study

Panuc Clinical Core

Posted Date: Mar 1, 2017

  • Investigator: Alberto Espay
  • Co-Investigator: Erin Neefus
  • Specialties: Parkinson's Disease, Neurology, Movement Disorders
  • Type of Study: Observational/Survey

The purpose of the Pacific Northwest Udall Center (or PANUC) is to study cognitive changes, or problems of thinking and memory in people who have Parkinson’s disease (PD) or a related disorder. The study will also evaluate genes that increase a person’s risk for PD and the likelihood of developing certain PD-related problems such as difficulties with thinking and memory. The Pacific Northwest Udall Center (or PANUC) has three missions. First, PANUC will serve patients with Parkinson’s disease (PD) and related neurodegenerative diseases, along with their caregivers and health care providers by providing improved education and offering new opportunities to participate in clinical research. Second, PANUC will investigate the causes of cognitive impairment, which is problems of thinking and memory, in people with PD and related neurodegenerative disease in order to help to identify future therapies to treat this problem. Third, PANUC will create new knowledge and generate novel resources for both basic laboratory research and clinical research to be shared with the community of scientists who are studying PD and related neurodegenerative diseases.

Criteria:

You Are Being Asked To Participate In The Panuc Study Because You Are Greater Than 18 Years Of Age And Either You Or One Of Your Family Members Has Been Given A Diagnosis Of Pd (Or A Related Condition) In The Past.

Keywords:

Panuc, Parkinson's Disease Dementia, Memory Loss And Parkinson's Disease, Espay, Cognitive Impairment

For More Information:

Katie Krier
(513) 558-0169
katie.krier@uc.edu

  • Search Clinical Studies

  • Research in the News

    Therapy After Surgical Removal of Rare Tumors May Not Increase Survival

    Results of an analysis show that additional therapy delivered after surgicalremoval of a rare type of gastrointestinal tumor does not increase survivalrates for patients.